Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLUTO: Sotagliflozin in Type 1 Diabetes with CKD
NCT06147232Phase 2Not yet recruiting
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Feb 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sotagliflozin in diabetic kidney disease (DKD), sponsored by Steno Diabetes Center Copenhagen. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
sotagliflozin
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT06147232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06147232.